RM5-44542-43601
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 019 / MA
- Registered
- 2021-03-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
SWB-14632-04715
Child or adolescent in my care · Male · 2022-06-30
Timeline
-
2021-03-14
Registered in v-safe
-
2021-03-14
Dose 1 — Pfizer-BioNTech
-
2021-03-14
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-14
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Muscle or body aches, NauseaAdult check-in
- 2021-03-16
- 2021-03-17
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-28
-
2021-04-04
Dose 2 — Pfizer-BioNTech
-
2021-04-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling, Itching · NauseaAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
- 2021-04-08
- 2021-04-09
- 2021-04-10
-
2021-04-11
Health check-in — day 7, dose 2Feeling: Fair · Fever · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-04-18
- 2021-04-25
- 2021-05-02
- 2021-05-11
- 2021-05-18
-
2021-07-04
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis — Feeling: FairFree text: Cold symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2022-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-14 | Pfizer-BioNTech | |
| 2 | 2021-04-04 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 9 — 3 months, dose 2
Symptoms: Cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release